TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2694978

Group type: EXPERIMENTAL
Intervention: Thiabendazole 2 x 25 mg kg‐1 day‐1
Number of subjects: 34

Group type: COMPARATOR
Intervention: Albendazole 2 x 5 mg kg‐1 day‐1
Number of subjects: 34
Study: 973982

Group type: EXPERIMENTAL
Intervention: HSA-Tc 99m instilled intranasally as drops
Number of subjects: 11

Group type: COMPARATOR
Intervention: HSA-Tc 99m instilled intranasally as spray
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: HSA-Tc 99m instilled intranasally (varied volume 0.10 ml to 0.75 ml, concentration 3% to 30%)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pertechnetate in isotonic saline
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Frequent administration by drops
Number of subjects: 11
Study: 30285186

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health Promotion (HP)
Number of subjects: 192
Study: 28675091

Group type: EXPERIMENTAL
Intervention: Coffee polyphenols (CPPs) 270 mg/100 mL/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 49
Study: 24965855

Group type: EXPERIMENTAL
Intervention: Cognitive water-based exercise (Cog-WE)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal water-based exercise (Nor-WE)
Number of subjects: 21
Study: 23777672

Group type: EXPERIMENTAL
Intervention: Counseling intervention aimed at adopting healthy lifestyle behaviors
Number of subjects: 622

Group type: COMPARATOR
Intervention: Control group receiving health brochures
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Counseling intervention for participants who finished secondary school
Number of subjects: 622

Group type: COMPARATOR
Intervention: Control group for participants who finished secondary school
Number of subjects: 622
Study: 21342016

Group type: EXPERIMENTAL
Intervention: Maternal knowledge about infant health benefits; comfort with breastfeeding in social settings
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Disagreement with the statement 'Infant formula is as good as breastmilk'
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Agreement that breastfed infants were less likely to develop ear infections, respiratory infections, diarrhea, and obesity
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Comfort breastfeeding in public
Number of subjects: 883
Study: 19390480

Group type: EXPERIMENTAL
Intervention: 2.7 g omega-3 LCPUFA supplementation
Number of subjects: 145

Group type: COMPARATOR
Intervention: 2.8 g soybean oil as placebo
Number of subjects: 145
Study: 16489946

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (ERL1: 100 mJ; ERL2: 120 mJ; ERL3: 140 mJ; 10 Hz)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vector ultrasonic system (VUS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hand instruments (SRP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated teeth (Control)
Number of subjects: 12
Study: 15324779

Group type: EXPERIMENTAL
Intervention: Opioid receptor binding in patients with CNP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age-matched pain-free controls
Number of subjects: 0
Study: 11387274

Group type: EXPERIMENTAL
Intervention: Normegon (25:75 IU/ampoule of LH and FSH)
Number of subjects: 27

Group type: COMPARATOR
Intervention: rFSH (75 IU/ampoule of FSH alone)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study: 9418687

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Spironolactone (100 mg)
Number of subjects: 40
Study: 8983932

Group type: EXPERIMENTAL
Intervention: Droxicam alone (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Droxicam with antacid (Mucal powder)
Number of subjects: 12
Study: 2921100

Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Atenolol (long-term treatment)
Number of subjects: 15
Study: 30470978

Group type: EXPERIMENTAL
Intervention: Nurse Navigation Program
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (non-navigated)
Number of subjects: 110
Study: 30948288

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 154

Group type: COMPARATOR
Intervention: Oral acetaminophen
Number of subjects: 154
Study: 27663600

Group type: EXPERIMENTAL
Intervention: Olaparib 200 mg twice daily + carboplatin AUC4
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Olaparib 100 or 200 mg twice daily (days 1-7) + carboplatin AUC4 or 5 every 21 days
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Olaparib with carboplatin
Number of subjects: 77
Study: 25503053

Group type: EXPERIMENTAL
Intervention: E-cigarette awareness
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: E-cigarette use trend
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: E-cigarette advertisement exposure trend
Number of subjects: 944

Group type: COMPARATOR
Intervention: Advertisement exposure comparison
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Advertisement exposure association
Number of subjects: 944
Study: 24077548

Group type: EXPERIMENTAL
Intervention: biperiden (akineton)
Number of subjects: 35

Group type: COMPARATOR
Intervention: trihexyphenidyl
Number of subjects: 35
Study: 21601250

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 90
Study: 19483074

Group type: EXPERIMENTAL
Intervention: poly‐L‐lactic acid polymer tack implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: polygluconate‐B polymer tack implants
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: both implant types
Number of subjects: 40
Study: 16508932

Group type: EXPERIMENTAL
Intervention: MTX plus infliximab (3 mg/kg or 6 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX plus placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 0
Study: 12956498

Group type: EXPERIMENTAL
Intervention: Laser-welded titanium framework
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional cast framework
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Titanium framework prosthesis
Number of subjects: 42
Study: 11079278

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Metoprolol plus glucagon 1 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 22
Study: 9522324

Group type: EXPERIMENTAL
Intervention: Transdermal 17‐β‐estradiol (50 μg/day)
Number of subjects: 9
Study: 8322374

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cardiac arrest
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Age-related atrophy
Number of subjects: 140
Study: 3108007

Group type: EXPERIMENTAL
Intervention: Saline plus naloxone (40 micrograms kg‐1 h‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 8
Study: 29509929

Group type: EXPERIMENTAL
Intervention: RSVcps2 (105.3 PFU, intranasal)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29084312

Group type: EXPERIMENTAL
Intervention: Patient navigation and financial incentives for smoking cessation (up to 4 hours of navigation over 6 months)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control group (enhancement of usual care)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for older participants (intervention)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for women (intervention)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for participants with household income of $20000 or less (intervention)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for nonwhite participants (intervention)
Number of subjects: 352
Study: 26125705

Group type: EXPERIMENTAL
Intervention: Zhikang capsule in addition to conventional dressing changes
Number of subjects: 98

Group type: COMPARATOR
Intervention: Regular dressing changes (observation group)
Number of subjects: 98
Study: 23418154

Group type: EXPERIMENTAL
Intervention: Intermittent exercise (INT) - 12 hourly, 5-min bouts
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Continuous exercise (EX) - 1-h exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sedentary behavior (SED) - control condition
Number of subjects: 11
Study: 21438717

Group type: EXPERIMENTAL
Intervention: VR‐I (conventional VR setup)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: VR‐II (VR environment with additional kinematic interaction)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Box‐I (box trainer equivalent of VR‐I)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Box‐II (box trainer equivalent of VR‐II)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 18376181

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGBP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 32
Study: 16755339

Group type: EXPERIMENTAL
Intervention: VDD(R) Saphir 3 device with nondedicated leads (Group 1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: VDD(R) Saphir 3 device with dedicated leads (Group 2)
Number of subjects: 45
Study: 14585524

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Estradiol Hemihidrate 2 mg + Norethindron Asetate 1 mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol 2 mg/day
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (pre-therapy values)
Number of subjects: 75
Study: 10826420

Group type: EXPERIMENTAL
Intervention: W-pouch
Number of subjects: 24

Group type: COMPARATOR
Intervention: J-pouch
Number of subjects: 24
Study: 8852738

Group type: EXPERIMENTAL
Intervention: Blunt needle (HR48PP = protect point)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sharp needle (HR48)
Number of subjects: 100
Study: 1627981

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6442055

Group type: EXPERIMENTAL
Intervention: Auranofin (Ridaura)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Na-auro-thiomalate (Tauredon)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 121
Study: 30610067

Group type: EXPERIMENTAL
Intervention: Treat-to-target approach
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study: 29396509

Group type: EXPERIMENTAL
Intervention: Sleep deprivation driving session
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal sleep driving session
Number of subjects: 9
Study: 27460108

Group type: EXPERIMENTAL
Intervention: Individualised herbs prescribed by a Chinese herbal practitioner
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standardised herbs provided by primary care clinicians
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both arms (individualised and standardised herbs)
Number of subjects: 80
Study: 24320728

Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Rupatadine
Number of subjects: 70
Study: 22825293

Group type: EXPERIMENTAL
Intervention: Transparent sterile dressing
Number of subjects: 703

Group type: COMPARATOR
Intervention: Standard dressing (non sterile sticking plaster)
Number of subjects: 703
Study: 19320546

Group type: EXPERIMENTAL
Intervention: Rostrolateral prefrontal cortex (RLPFC) activation during relational integration trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hippocampus activation during relational encoding trials
Number of subjects: 0
Study: 18044285

Group type: EXPERIMENTAL
Intervention: Intraoperative music (Spanish guitar)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (white noise)
Number of subjects: 100
Study: 15695500

Group type: EXPERIMENTAL
Intervention: Fludarabine-mitoxantrone (FM)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP)
Number of subjects: 155
Study: 11872997

Group type: EXPERIMENTAL
Intervention: 3.95% THC marijuana cigarettes
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Dronabinol 2.5 mg capsules
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 62
Study: 10194038

Group type: EXPERIMENTAL
Intervention: Intravenous tacrolimus followed by oral therapy and mycophenolate mofetil (MMF) with a fixed dose of 2 g/day in Phase I and adjusted doses in Phase II based on mycophenolic acid (MPA) plasma levels.
Number of subjects: 45
Study: 7566846

Group type: EXPERIMENTAL
Intervention: Operative laparoscopy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 40
Study: 2109639

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 17
Study: 7375940

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31932567

Group type: EXPERIMENTAL
Intervention: Delirium intervention (not specified in detail)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Risk factors affecting delirium (e.g., age over 65, unconsciousness, dependent activities, abnormal vital signs, pressure ulcer risk, enteral nutrition, use of restraint)
Number of subjects: 1000
Study: 28325532

Group type: EXPERIMENTAL
Intervention: Binaural beats (200Hz for left ear and 209.3Hz for right ear)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 25527053

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 577

Group type: COMPARATOR
Intervention: Successful stent placement
Number of subjects: 577

Group type: COMPARATOR
Intervention: No stent attempt
Number of subjects: 577
Study: 23653274

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg fasting and 5 mg at bedtime)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23964473

Group type: EXPERIMENTAL
Intervention: St. John's Wort extract WS 5570, 600 mg once daily for 8 to 10 weeks
Number of subjects: 1300

Group type: COMPARATOR
Intervention: St. John's Wort extract WS 5570, 600 mg once daily
Number of subjects: 1300
Study: 20046574

Group type: EXPERIMENTAL
Intervention: huCD25mAb
Number of subjects: 15

Group type: COMPARATOR
Intervention: daclizumab
Number of subjects: 15
Study: 17287448

Group type: EXPERIMENTAL
Intervention: APOE4 status, Symbol Digit Modalities Test, Delayed 10‐Word List Recall, New York University Paragraph Recall Test (Delayed), ADAS‐cog total score
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: APOE4 status removed from analysis
Number of subjects: 539
Study: 15051210

Group type: EXPERIMENTAL
Intervention: Corneal aberrations measured at various time intervals after a blink (0, 10, and 20 seconds)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Total ocular aberrations measured at various time intervals after a blink (0, 10, and 20 seconds)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Optical quality metric (Mf) measured after a blink
Number of subjects: 20
Study: 11903211

Group type: EXPERIMENTAL
Intervention: Structured one-to-one education
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 160
Study: 9550241

Group type: EXPERIMENTAL
Intervention: Scheduled intermittent hospitalization (four hospital admissions lasting nine to 11 days each, per year for two years)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Traditional access to hospital care
Number of subjects: 57
Study: 8174440

Group type: EXPERIMENTAL
Intervention: Omeprazole (60 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancreatin monotherapy
Number of subjects: 0
Study: 3359658

Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 29246532

Group type: EXPERIMENTAL
Intervention: Sanoia platform access after minimal training
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study: 27219520

Group type: EXPERIMENTAL
Intervention: Full-length renal artery ablation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Proximal renal artery ablation
Number of subjects: 47
Study: 24942611

Group type: EXPERIMENTAL
Intervention: Stress positron emission tomography (PET) with regadenoson
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 50
Study: 22318648

Group type: EXPERIMENTAL
Intervention: Free consumption of fruits and vegetables (less than 75 mg phenylalanine per 100 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional treatment (accounting for protein from fruits and vegetables)
Number of subjects: 14
Study: 20505547

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE)
Number of subjects: 10739

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10739
Study: 18783399

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.0 mg/m²
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m²
Number of subjects: 54
Study: 16995860

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg twice daily for 6 weeks
Number of subjects: 2

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2
Study: 12877250

Group type: EXPERIMENTAL
Intervention: Sperm extraction 24 hours before ovum pickup
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sperm extraction on the day of oocyte retrieval
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cryopreservation of sperm retrieved on the day of ovum pickup
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cryopreservation of sperm retrieved 24 hours before oocyte retrieval
Number of subjects: 54
Study: 10750566

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menatetrenone) 45 mg/day orally
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control (without treatment)
Number of subjects: 241
Study: 9363656

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional intermittent mandatory ventilation (CIMV)
Number of subjects: 77
Study: 1588147

Group type: EXPERIMENTAL
Intervention: PRP vaccine
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 3886024

Group type: EXPERIMENTAL
Intervention: L-tryptophan (12 g/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: L-tryptophan (continued treatment)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (switched from L-tryptophan)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: L-tryptophan (increased synthesis of 5-hydroxytryptamine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: L-tryptophan (in men)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: L-tryptophan (in women)
Number of subjects: 24
Study: 29921800

Group type: EXPERIMENTAL
Intervention: Moderately-high-protein diet
Number of subjects: 147

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 147
Study: 26853287

Group type: EXPERIMENTAL
Intervention: L-lysine (3 g/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metformin and glibenclamide (standard treatment for both groups)
Number of subjects: 50
Study: 24281237

Group type: EXPERIMENTAL
Intervention: 25 mg testosterone enanthate
Number of subjects: 71

Group type: COMPARATOR
Intervention: 3 mg testosterone enanthate
Number of subjects: 71

Group type: COMPARATOR
Intervention: 6.25 mg testosterone enanthate
Number of subjects: 71

Group type: COMPARATOR
Intervention: 12.5 mg testosterone enanthate
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 23427401

Group type: EXPERIMENTAL
Intervention: Wuziyanzong treatment (2.30, 4.60, 9.20 g/kg crude drug) for 30 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (distilled water)
Number of subjects: 50
Study: 20487057

Group type: EXPERIMENTAL
Intervention: Listening to music 15 min before and during turning
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 17
Study: 18279551

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (50 mg/d)
Number of subjects: 29023

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/d)
Number of subjects: 29023

Group type: COMPARATOR
Intervention: Control group (not supplemented with vitamin E)
Number of subjects: 29023
Study: 16463853

Group type: EXPERIMENTAL
Intervention: Lumbar Epidural Pressure (LEDP) monitoring
Number of subjects: 150

Group type: COMPARATOR
Intervention: Repeated lumbar puncture at 24, 48, 72, and 96 hours
Number of subjects: 150
Study: 12848775

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m² with Zosuquidar 3HCl
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Paclitaxel 225 mg/m² with Zosuquidar 3HCl
Number of subjects: 43

Group type: COMPARATOR
Intervention: Paclitaxel alone (175 mg/m² or 225 mg/m²)
Number of subjects: 43
Study: 10596681

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No NOT (control)
Number of subjects: 76
Study: 9124781

Group type: EXPERIMENTAL
Intervention: Shouldice operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional open hernia surgery
Number of subjects: 0
Study: 1853691

Group type: EXPERIMENTAL
Intervention: PUR-cannulae
Number of subjects: 37

Group type: COMPARATOR
Intervention: PTFE-cannulae
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: In vitro through latex membranes
Number of subjects: 37
Study: 6871055

Group type: EXPERIMENTAL
Intervention: 0.8% prilocaine (4 mg/kg body weight)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5% prilocaine (4 mg/kg body weight)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2% prilocaine (4 mg/kg body weight)
Number of subjects: 60
Study: 30529477

Group type: EXPERIMENTAL
Intervention: EXERCISE NUTRITION
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: EXERCISE PLACEBO
Number of subjects: 38

Group type: COMPARATOR
Intervention: NUTRITION
Number of subjects: 38

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 38
Study: 29446452

Group type: EXPERIMENTAL
Intervention: Older children setting reminders when expecting poorer future memory performance
Number of subjects: 63

Group type: COMPARATOR
Intervention: Younger children
Number of subjects: 63